<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00289471</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 05-112</org_study_id>
    <nct_id>NCT00289471</nct_id>
  </id_info>
  <brief_title>Identifying Patients With Dementia in Primary Care</brief_title>
  <acronym>GEMS</acronym>
  <official_title>Dementia in Primary Care: Setting the Stage for Quality Improvement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Veterans who completed GEMS-Phase 1 will be asked to participate in GEMS-Phase 2 to determine
      the accuracy of methods used to assess mild memory problems. This will better help us
      evaluate the screening test completed in GEMS-Phase 1. The goals are:

        1. Compare the assessment of memory made at the initial visit to assessments of memory made
           at the second evaluation.

        2. Determine of veterans with mild memory problems have improvement or worsening of these
           memory problems over time. Our long-term goal remains to optimize the quality of care
           for veterans with cognitive impairment. We will also determine if patient
           characteristics can be used to target case-finding, describe the current process of care
           and evaluate the association between cognitive impairment and overall- and
           dementia-related health care utilization and costs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dementia has high public health significance due to its prevalence, adverse impact on
      patients and caregivers, high economic cost to society and the rapidly expanding numbers of
      individuals age 65 and older. As the largest provider of geriatric care in the U.S., dementia
      is particularly relevant to the Veterans Health Administration (VHA). However, only a small
      proportion of patients with dementia are diagnosed early when treatments are most effective
      and the opportunity for careful life planning remains, in part because of the absence of
      feasible, well-validated case-finding instruments. Our long-term objective is to improve the
      care and outcomes of veterans with clinically significant cognitive impairment. The first
      steps towards realizing this objective are to determine the acceptability of cognitive
      screening to patients and to identify feasible, valid case-finding tools for primary care. We
      will also determine if patient characteristics can be used to target case-finding, describe
      the current process of care and evaluate the association between cognitive impairment and
      overall- and dementia-related health care utilization and costs. Our research team, located
      in the Center for Health Services Research in Primary Care, brings together researchers
      uniquely suited to achieving this objective. Specific Aims1.Primary Aim: To determine if
      cognitive screening is acceptable to patients, and whether brief cognitive screeners perform
      as well as the longer Modified Mini-Mental Status Exam (3MS) for dementia and cognitive
      impairment-not dementia (CIND).Primary Hypothesis 1: Higher perceived risk of dementia,
      higher perceived benefits and fewer perceived harms from screening will be positively
      associated with screening acceptance. Primary Hypotheses 2: Compared to the 3MS, the
      Mini-Cog, Memory Impairment Screen and 2-item functional screen will have similar performance
      characteristics. 2.Secondary Aim 1: To determine if sociodemographic and clinical
      characteristics available in the electronic medical record can be used to target individuals
      for cognitive screening and improve screening accuracy. Hypothesis: The combination of
      sociodemographic characteristics/clinical information and screening results will more
      accurately discriminate between demented and non-demented patients than screening results
      alone.3.Secondary Aim 2: To describe current care for an inception cohort with dementia or
      cognitive impairment-not dementia. Hypothesis: Compared to patients with dementia, patients
      with cognitive impairment-not dementia will undergo less diagnostic testing, be less likely
      to complete an advanced directive and be less likely to receive dementia specific
      medications. 4.Exploratory Aim: To evaluate the association between cognitive impairment and
      overall- and dementia-related health care utilization and costs. Exploratory Hypothesis:
      Controlling for sociodemographic characteristics and medical comorbidity, overall healthcare
      utilization and costs will increase as cognitive impairment increases. In phase 1, a random
      sample of primary care patients age 65 years will be recruited from 3 primary care clinics to
      complete the Modified Dementia Screening Acceptance and Perceived Harms Questionnaire. In
      phase 2, patients will complete three brief instruments and the standard 15-item 3MS that
      will be compared to a criterion standard interview for dementia. We project 140-200 patients
      will have dementia, 200-300 CIND, and approximately 600 will be cognitively normal.
      Instruments will be compared using sensitivity/specificity, likelihood ratios and receiver
      operating characteristic curves. The emotional impact of screening will be assessed following
      screening. Clinical and sociodemographic characteristics available in the Computerized
      Patient Record System, together with cognitive screening results, will be analyzed with
      logistic regression models to identify risk factors that may be used to target individuals
      for cognitive screening and/or improve screening accuracy. Care patterns for patients with
      dementia and CIND will be described based on detailed chart abstractions. For the exploratory
      analysis on cognitive impairment and utilization, two-part utilization models will be
      estimated for each utilization type, outpatient clinic visits, inpatient visits, pharmacy
      utilization, and other utilization types; utilization data will be obtained from
      administrative data.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Performance Characteristics</measure>
    <time_frame>Cross-sectional [at baseline; no longitudinal component]</time_frame>
    <description>Sensitivity and Specificity for Modified Mini-Mental Status Examination (MMSE), a measure scored 0-100 to assess cognitive impairment</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">630</enrollment>
  <condition>Dementia</condition>
  <condition>Memory Disorders</condition>
  <arm_group>
    <arm_group_label>Cognitive Screening</arm_group_label>
    <description>Cognitive screening</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention delivered.</intervention_name>
    <description>No intervention delivered.</description>
    <arm_group_label>Cognitive Screening</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Veterans' who have previously completed GEMS-Phase 1 testing, continues to be a VA clinic
        patient and identifies a key family member or friend who will answer questions about the
        veteran's memory and daily activities.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previous participant who completed GEMS-Phase 1

          -  Continues to be a VA clinic patient

          -  Identifies a key informant with phone

        Exclusion Criteria:

          -  Severe hearing or visual impairment

          -  Acute medical condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John W Williams, MD MHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Durham VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Durham VA Medical Center HSR&amp;D COE</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Plassman BL, Williams JW Jr, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med. 2010 Aug 3;153(3):182-93. doi: 10.7326/0003-4819-153-3-201008030-00258. Epub 2010 Jun 14. Review.</citation>
    <PMID>20547887</PMID>
  </results_reference>
  <results_reference>
    <citation>Holsinger T, Plassman BL, Stechuchak KM, Burke JR, Coffman CJ, Williams JW Jr. Screening for cognitive impairment: comparing the performance of four instruments in primary care. J Am Geriatr Soc. 2012 Jun;60(6):1027-36. doi: 10.1111/j.1532-5415.2012.03967.x. Epub 2012 May 30.</citation>
    <PMID>22646750</PMID>
  </results_reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2006</study_first_submitted>
  <study_first_submitted_qc>February 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2006</study_first_posted>
  <results_first_submitted>August 11, 2014</results_first_submitted>
  <results_first_submitted_qc>August 11, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 26, 2014</results_first_posted>
  <last_update_submitted>April 10, 2015</last_update_submitted>
  <last_update_submitted_qc>April 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sensitivity and specificity</keyword>
  <keyword>Physician's practice patterns</keyword>
  <keyword>Health Care costs</keyword>
  <keyword>Quality of Health Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Memory Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Cognitive Screening</title>
          <description>Cognitive screening
No intervention delivered.: No intervention delivered.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="630"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="630"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cognitive Screening</title>
          <description>Cognitive screening
No intervention delivered.: No intervention delivered.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="630"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.8" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="585"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="461"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="630"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Performance Characteristics</title>
        <description>Sensitivity and Specificity for Modified Mini-Mental Status Examination (MMSE), a measure scored 0-100 to assess cognitive impairment</description>
        <time_frame>Cross-sectional [at baseline; no longitudinal component]</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cognitive Screening</title>
            <description>Cognitive screening
No intervention delivered.: No intervention delivered.</description>
          </group>
        </group_list>
        <measure>
          <title>Performance Characteristics</title>
          <description>Sensitivity and Specificity for Modified Mini-Mental Status Examination (MMSE), a measure scored 0-100 to assess cognitive impairment</description>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="630"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Sensitivity (%)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" lower_limit="64" upper_limit="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity (%)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="72" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Cross-sectional [at baseline; no longitudinal component]</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cognitive Screening</title>
          <description>Cognitive screening
No intervention delivered.: No intervention delivered.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="630"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="630"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John W. Williams</name_or_title>
      <organization>Durham VAMC</organization>
      <phone>919-286-6963</phone>
      <email>jw.williams@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

